Skip NavigationSkip to Content
Return Return to Search Results

Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts

  1. Author:
    Alcoser, S. Y.
    Kimmel, D. J.
    Borgel, S. D.
    Carter, J. P.
    Dougherty, K. M.
    Hollingshead, M. G.

  2. Author Address

    [Alcoser, Sergio Y.; Hollingshead, Melinda G.] NCI, Biol Testing Branch, Dev Therapeut Program, Div Canc Treatment & Diag, Frederick, MD 21701 USA. [Kimmel, David J.; Borgel, Suzanne D.; Carter, John P.; Dougherty, Kelly M.] NCI Frederick, Biol Testing Branch, Dev Therapeut Program, SAIC Frederick Inc, Frederick, MD USA.;Alcoser, SY (reprint author), NCI, Biol Testing Branch, Dev Therapeut Program, Div Canc Treatment & Diag, Frederick, MD 21701 USA;alcosers@mail.nih.gov
    1. Year: 2011
    2. Date: Dec
  2. Journal: BMC Biotechnology
    1. 11
  4. Type of Article: Article
  5. Article Number: 124
  6. ISSN: 1472-6750
  1. Abstract:

    Background: Xenograft samples used to test anti-cancer drug efficacies and toxicities in vivo contain an unknown mix of mouse and human cells. Evaluation of drug activity can be confounded by samples containing large amounts of contaminating mouse tissue. We have developed a real-time quantitative polymerase chain reaction (qPCR) assay using TaqMan technology to quantify the amount of mouse tissue that is incorporated into human xenograft samples. Results: The forward and reverse primers bind to the same DNA sequence in the human and the mouse genome. Using a set of specially designed fluorescent probes provides species specificity. The linearity and sensitivity of the assay is evaluated using serial dilutions of single species and heterogeneous DNA mixtures. We examined many xenograft samples at various in vivo passages, finding a wide variety of human: mouse DNA ratios. This variation may be influenced by tumor type, number of serial passages in vivo, and even which part of the tumor was collected and used in the assay. Conclusions: This novel assay provides an accurate quantitative assessment of human and mouse content in xenograft tumors. This assay can be performed on aberrantly behaving human xenografts, samples used in bioinformatics studies, and periodically for tumor tissue frequently grown by serial passage in vivo.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1186/1472-6750-11-124
  3. View record in Web of Science®
  4. WOS: 000300428100001

Library Notes

  1. Fiscal Year: FY2011-2012
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel